Leukemia

Rejection and lack of rejection

Immune Tolerance May Open New Horizons for Bone Marrow and Organ Transplants

05.02.2018

Cancer, Personalized Medicine, Nutrition, Stem Cells, Systems Biology, Viruses & Microorganisms, Molecular and Cell Biology, Immunology, Disease, Drugs & Diagnostics

An anticancer drug keeps recipient T cells from attacking donor cells

Prof. Eli Canaani

First Discovery of Cancer Produced by Protein Fusion

12.09.2010

Disease, Drugs & Diagnostics, Benefiting Humanity

Prof. Eli Canaani’s research provided the foundation for the development of Glivec, the first drug based on the molecular understanding of a...

Top Stories

Burning Cancer’s Bridges

Crystalizing Our Comprehension of Malaria

A tumor sample from a human patient with the most common type of lung cancer (adenocarcinoma). Senescent cells are highlighted by their expression of the p16 (red) and the PD-L1 (green) proteins. Cell nuclei are in blue

Unclogging the Immune System

MRI brain scans of mice with Gaucher disease Type III. The scan of a mouse that received the new treatment (left) shows a significant reduction in tissue inflammation (blue) compared to an untreated mouse (right)

Improving the Recipe for Gene Therapy

Press Releases

The Weizmann Institute of Science Ranked among the World’s Top Ten Academic Institutions

A Discovery to Set Your Heart a-Knocking

Navigating the Digestive Tract

Most Popular Articles

Checking the Dosage

Prof. Yoram Groner is a pioneer in Down syndrome research

The Limits of Computing

Computers can solve complex problems but they are far from omnipotent. Prof. Ran Raz of the Weizmann Institute's Computer Science and Applied Mathematics Department is trying to portray the limits...

Let it Rain

Added particles in the atmosphere could be affecting rainfall patterns